EP 2 817 000 B1 relates to oral pharmaceutical compositions comprising dabigatran etexilate mesylate.
Brief outline of the case
The OD decided maintenance according a new MR= MRn.
Opponent 1 withdrew its opposition and opponents 2+3 appealed.
The board held that claim 1 as maintained lacked IS over D1=WO 2012/001156.